Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial

Detalles Bibliográficos
Autores principales: Hannawi, Suad, Saifeldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Li, Jian, Chen, Yuanxin, Xie, Liangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731927/
https://www.ncbi.nlm.nih.gov/pubmed/36509358
http://dx.doi.org/10.1016/j.jinf.2022.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731927/
https://www.ncbi.nlm.nih.gov/pubmed/36509358
http://dx.doi.org/10.1016/j.jinf.2022.12.003

Ejemplares similares